Nucleic Acid Isolation & Purification Market by Product (Kits, Reagents, and Instruments), Type (Plasmid DNA Isolation & Purification, Total RNA Isolation & Purification, Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, microRNA Isolation & Purification, PCR Cleanup, and Others), Method (Column-Based Isolation & Purification, Magnetic Bead-based Isolation & Purification, Reagent-based Isolation & Purification, and Others), Application (Diagnostics, Drug Discovery & Development, Personalized Medicines, Agriculture & Animal Research, and Others), End User (Hospitals & Diagnostic Centers, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others): Global Market Size Estimates and Forecast (2022-2030)

The market crossed US$ 6.0 billion mark in 2022 and is expected to hit US$ 10.0 billion by 2030, recording a CAGR of 8.0% during the forecast period.

What you need to know about Nucleic Acid Isolation & Purification?

Technological advancement is a standalone factor responsible for driving the nucleic acid isolation & purification market. Nucleic acid sample purification and quality assessment prove to be a critical process in experimental workflows as the quality of nucleic acids can affect the performance of downstream reactions; technological advancements prove to be a vital factor. Additionally, various companies manufacture technologically advanced kits for nucleic acid isolation & purification activity. For example, Thermo Fischer Scientific, Inc.'s "KingFisher Automated Extraction & Purification System" is the most versatile automation kit utilized in the lab to consistently extract and purify DNA, RNA, protein, and cells. Moreover, the KingFisher system technology offers an efficient workflow solution. Such technologically advanced kits are ultimately responsible for the overall growth of the nucleic acid isolation & purification market during the forecast period. The kits segment is expected to pace up with the wide-scale application of kits and reagents for DNA and RNA isolation for preparing samples and libraries, and the low cost and easy usage of kits. Further, the instruments segment such as the launch of new instruments facilitating automation, rapid technological innovation, and growing demand for automated nucleic acid isolation and purification instruments is also expected to gain traction during the forecasted year.

Within the report, the market is segmented into product, type, method, application, end user, and geography. On the basis of product, the market is further segregated as Kits, Reagents, and Instruments. By type, the market is segmented as plasmid DNA isolation & purification, total RNA isolation & purification, circulating nucleic acid isolation & purification, genomic DNA isolation & purification, messenger RNA isolation & purification, microRNA isolation & purification, PCR cleanup, and others. By the method, the market is segregated as Column-based isolation & purification, magnetic bead-based isolation & purification, reagent-based isolation & purification, and others. Further, by end user, the market is segregated into hospitals & diagnostic centers, academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.

COVID-19 impact on nucleic acid isolation & purification market.

With the COVID-19 pandemic, there has been an accelerating demand for testing and drug research about the disease. Research in this area further strengthens the testing capacity expected to enhance the nucleic acid and isolation purification field. Moreover, there are several developments by the top competitive manufacturers aiming to develop innovative products for increasing patient access to coronavirus diagnostic testing and vaccine and drug development in laboratories and hospitals for patient counseling and protect public health. The aforementioned factors are responsible for the overall growth of the nucleic acid isolation & purification market amid the pandemic.

Hospitals & Diagnostic Centers segment showcases high growth of nucleic acid isolation & purification market.

Based on end-users, the hospitals & diagnostic centers segment can be attributed to rising research & development (R&D) activities and the utility of nucleic acid tests for molecular diagnostics. Further, DNA/RNA isolation and purification techniques are considered efficient tools for diagnosing genetic diseases involving sickle cell anemia, hemophilia A, and Tay-Sachs disease. Therefore, the availability of such efficient technologies at moderate prices increases the adoption of such technology-based kits at diagnostic centers & hospitals. Such aforementioned factors are responsible for the overall market growth of the global hospitals & diagnostic centers market during the forecast period.

Get more information on this report : Request Free Sample PDF

Recent strategic developments in nucleic acid isolation & purification market

The nucleic acid isolation & purification market has undergone several significant developments, and a few of these have been mentioned below:

• In June 2019, Biogenuix, announced launching of automated nucleic acid extraction systems from KURABO INDUSTRIES LTD. (Japan). The newly launched product has contributed to numerous genetic researches over 20 years by DNA/RNA isolation systems, GENE PREP STAR and QuickGene.
• In April 2021, Thermo Fischer Scientific, Inc. announced launching o f a new product namely, Thermo Scientific KingFisher Apex Purification System". This newly launched product is a high-throughput sample purification instrument designed for scientists seeking for automation for extraction of DNA, RNA, proteins and cells from an array of sample types. The product is simple to use, saves time, and enables consistent results.

The nucleic acid isolation & purification market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. QIAGEN, Thermo Fischer Scientific, Inc., F. Hoffmann-La Roche Ltd, Merck KGaA (Sigma Aldrich), Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Danaher, Takara Bio Inc., Promega Corporation, and Biogenuix are among the prominent players operating in the market.

Target audience for the report:

• Nucleic acid isolation & purification service providers
• Nucleic acid isolation & purification related associations, organizations, forums, and alliances
• Government bodies, such as regulating authorities and policy makers
• Venture capitalists, private equity firms, and start-up companies
• End users of Nucleic acid isolation & purification
• Research institutes, organizations, and consulting companies

Scope of the report:

In this report, the market has been segmented on the basis of:

• Product:
  • Kits,
  • Reagents,
  • Instruments
• Type
  • Plasmid DNA Isolation & Purification
  • Total RNA Isolation & Purification
  • Circulating Nucleic Acid Isolation & Purification
  • Genomic DNA Isolation & Purification
  • Messenger RNA Isolation & Purification
  • microRNA Isolation & Purification
  • PCR Cleanup
  • Others
• Method:
  • Column-Based Isolation & Purification
  • Magnetic Bead-based Isolation & Purification
  • Reagent-based Isolation & Purification
  • Others
• Application:
  • Diagnostics
  • Drug Discovery & Development
  • Personalized Medicines
  • Agriculture & Animal Research
  • Others
• End User:
  • Hospitals & Diagnostic Centers
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Others
• Region
  • North America
  • Europe
  • Asia Pacific (APAC)
  • South & Central America
  • Middle East & Africa
• Companies profiled
  • QIAGEN
  • Thermo Fischer Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA (Sigma Aldrich)
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Danaher
  • Takara Bio Inc.
  • Promega Corporation
  • Biogenuix